Transgene Biotek P/E Ratio

Transgene Biotek P/E ratio. Transgene Biotek (TRABI) P/E ratio is not applicable — EPS (TTM) ₹-0.22, 8 consecutive loss quarters. See Healthcare peers with valid P/E ratios below.

P/E Ratio Status
N/A
Loss Making
Company is currently reporting losses
P/E Ratio Not Applicable

Company has been reporting losses for 8 consecutive quarters. P/E ratio cannot be calculated for loss-making companies.

Consecutive Loss Quarters: 8

Current EPS: ₹-0.22

Recent Quarterly Performance

Quarter EPS (₹) Net Profit (₹ Cr) Status
Mar 2026 -0.06 -1 Loss
Jun 2026 -0.05 0 Loss
Sept 2025 -0.05 0 Loss
Mar 2025 -0.09 -1 Loss
Jun 2025 -0.06 0 Loss
Dec 2025 -0.05 0 Loss
Sept 2024 -0.01 0 Loss
Mar 2024 -0.04 0 Loss

Healthcare Peers with Valid P/E Ratios — TRABI Comparison

Healthcare sector average P/E 52.19, median 29.6 — TRABI excluded (negative EPS).

Sector Average PE
52.19
Sector Median PE
29.6
Lowest PE
2.0
Profitable Companies
256
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.0 ₹72 Low
Brooks Laboratories BROOKS 2.6 ₹206 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.3 ₹54 Low
Sun Pharma Advanced Rese… SPARC 4.1 ₹6,355 Low
Dipna Pharmachem DPL 4.5 ₹11 Low
JFL Life Sciences JFLLIFE 4.7 ₹82 Low
Royal Sense ROYAL 4.8 ₹34 Low
Star Imaging And Path Lab STARIMAGIN 5.3 ₹110 Low
Kabra Drugs KABRADG 6.3 ₹49 Low

Related Analysis